Sustained IL-6 and sTNF-αR1 levels after hip fracture predict 5-year mortality: A prospective cohort study from the Baltimore Hip Studies.
Saionara Maria Aires da CâmaraMarc C HochbergRam MillerAlice S RyanDenise OrwigAnn L Gruber-BaldiniJack GuralnikLaurence S MagderZhaoyong FengJason R FalveyBrock A BeamerJay MagazinerPublished in: Journal of the American Geriatrics Society (2024)
Persistent elevation of plasma IL-6 and sTNFα-R1 levels within the first 2 months after hospital admission in patients with hip fracture is associated with higher 5-year mortality. These patients may benefit from enhanced care and earlier intensive interventions to reduce the risk of death.
Keyphrases
- hip fracture
- healthcare
- end stage renal disease
- cardiovascular events
- ejection fraction
- newly diagnosed
- emergency department
- palliative care
- physical activity
- prognostic factors
- peritoneal dialysis
- cardiovascular disease
- patient reported outcomes
- pain management
- adverse drug
- health insurance
- patient reported
- case control